logo
Plus   Neg
Share
Email

Biogen To Acquire Clinical Stage PF-05251749 From Pfizer - Quick Facts

Biogen Inc. (BIIB) announced an agreement to acquire from Pfizer Inc. (PFE) PF-05251749, a CNS-penetrant small molecule inhibitor of casein kinase 1, for the potential treatment of patients with behavioral and neurological symptoms across various psychiatric and neurological diseases. The deal will include an upfront payment of $75 million with up to $635 million in potential additional development and commercialization milestone payments, as well as tiered royalties in the high single digits to sub-teens.

PF-05251749 has previously demonstrated an acceptable safety profile and proof of mechanism in a phase 1a clinical study. Biogen plans to develop this asset for the treatment of Sundowning in Alzheimer's disease and Irregular Sleep Wake Rhythm Disorder in Parkinson's disease. The company aims to initiate a phase 1b study in the fourth quarter of 2020.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walt Disney Co.'s (DIS) streaming service Disney+ will be launched on March 24 in the UK and other markets in the Western Europe, one week earlier than originally planned on March 31. Pricing also been confirmed at 5.99 pounds/6.99 euros per month or 59.99 pounds/69.99 euros for an annual subscription.... Facebook plans to add 1,000 new jobs in the UK this year, with more than half of this focused on technology. The new jobs come ahead of Facebook's planned opening of its new office premises in King's Cross, London next year. It will take the social media giant's total employee count in the UK to more than 4,000 by the end of this year. E-commerce giant Amazon is planning to add 10,000 electric vehicles or EVs to its delivery fleet in India by 2025, as part of its efforts to combat the severe climate change. These vehicles are in addition to Amazon's plan of adding 100,000 electric vehicles in its global delivery fleet by 2030, as per the Climate Pledge, which it co-founded and signed in September 2019.
Follow RTT
>